Cirugía y Especialidades Médico-Quirúrgicas
Departamento
EVA
ALLONCA CAMPA
Investigador/a
Publicaciones en las que colabora con EVA ALLONCA CAMPA (43)
2023
-
Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma
Nature Communications, Vol. 14, Núm. 1
2021
2020
-
Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 358-366
-
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
Cell Death and Disease, Vol. 11, Núm. 11
-
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma
Oral Oncology, Vol. 110
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
-
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas
Cancer Immunology, Immunotherapy, Vol. 69, Núm. 10, pp. 2089-2100
-
Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas
Cancers, Vol. 12, Núm. 7, pp. 1-15
-
Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications
Cancers, Vol. 12, Núm. 4
-
Tspan1: A novel protein involved in head and neck squamous cell carcinoma chemoresistance
Cancers, Vol. 12, Núm. 11, pp. 1-20
2019
-
Frequent alteration of annexin A9 and A10 in HPV-negative head and neck squamous cell carcinomas: Correlation with the histopathological differentiation grade
Journal of Clinical Medicine, Vol. 8, Núm. 2
-
PD-L1 expression in tumor cells is an independent unfavorable prognostic factor in oral squamous cell carcinoma
Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 3, pp. 546-554
-
SOX2 expression is an independent predictor of oral cancer progression
Journal of Clinical Medicine, Vol. 8, Núm. 10
-
The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
Journal of Clinical Medicine, Vol. 8, Núm. 8
-
The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma
Cancers, Vol. 11, Núm. 11
-
The emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders
Journal of Clinical Medicine, Vol. 8, Núm. 9
-
The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas
International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266
2018
-
Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients
Journal of Clinical Medicine, Vol. 7, Núm. 12
-
Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading
Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813